Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur Rev Med Pharmacol Sci ; 28(6): 2493-2500, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38567609

RESUMEN

OBJECTIVE: The present study aimed to compare the effect of topical laryngeal lidocaine with intravenous lidocaine before endotracheal intubation on the incidence and severity of postoperative sore throat, hoarseness, and cough. PATIENTS AND METHODS: This prospective randomized controlled study enrolled 144 patients undergoing laparoscopic cholecystectomy with endotracheal intubation. The patients were randomized to three groups and received 2% lidocaine by topical laryngeal spray (group T), intravenous 2% lidocaine (group I), and the equivalent volume of intravenous saline (group C) before intubation. The incidence and severity of sore throat, hoarseness, and cough reaction at 0.5, 1, 6, and 24 h after extubation were collected. RESULTS: The incidence of sore throat was significantly lower in group T than in groups I and C (6.4% vs. 37.2% and 86.7%, p < 0.001), respectively at 0.5 h after extubation, and it was significantly lower in group I than that in group C (37.2% vs. 86.7%, p < 0.001). Both the incidence of hoarseness and cough were significantly lower in group T than in group I and in group C (14.9% vs. 97.7% and 97.8%, p < 0.001, and 19.1% vs. 72.0% and 93.3%, p < 0.001), respectively. The severity of sore throat, hoarseness and cough in group T was significantly lower than that in group I and that in group C (p < 0.05), and it was significantly lower in group I than in group C (p < 0.05). CONCLUSIONS: Both topical laryngeal lidocaine and intravenous lidocaine before intubation have positive effects on preventing sore throat. Topical laryngeal route was superior to intravenous route. Chictr.org.cn ID: ChiCTR2100042442.


Asunto(s)
Anestésicos Locales , Faringitis , Humanos , Extubación Traqueal/efectos adversos , Anestésicos Locales/uso terapéutico , Tos/etiología , Tos/complicaciones , Ronquera/epidemiología , Ronquera/etiología , Ronquera/prevención & control , Intubación Intratraqueal/efectos adversos , Lidocaína/uso terapéutico , Faringitis/epidemiología , Faringitis/etiología , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Estudios Prospectivos
2.
Zhonghua Wai Ke Za Zhi ; 61(12): 1051-1057, 2023 Dec 01.
Artículo en Chino | MEDLINE | ID: mdl-37932140

RESUMEN

Intravenous leiomyomatosis is a rare type of tumor that is histologically benign but biologically invasive. It originates from the smooth muscle of the uterine or the uterine vein. It can grow through the uterus and extend into the pelvic cavity, or grow along the veins without invading the wall of the venous vessel itself. The tumors are estrogen-dependent and can metastasize through the bloodstream. Thus, in addition to continuous growth, some tumors exhibit isolated growths in the venous system and heart chambers or show disseminated growth in the lungs, although distant metastasis to other regions usually do not occur. Currently, there is limited research on this disease, the majority of which are case reports, surgical experience summaries, and differentiation from ordinary gynecological myomas in terms of pathogenesis and radiological diagnostic experience. There are two main theories on the origin of the disease: uterine smooth muscle and smooth muscle of the uterine veins. Some studies have verified the role of estrogen, progesterone receptor-related pathways, and angiogenesis in the development of the disease. The clinical symptoms of this disease are varied, depending on the affected area. In the early stages, when the tumor only affects the pelvic cavity, patients show mild symptoms resulting from pelvic organ compression. When it progresses to the inferior vena cava and heart, patients show more complex symptoms resulting from venous return obstruction, cardiac obstruction, and hemodynamics appearing. Different institutions have proposed different disease staging and classification strategies for different clinical purposes. Some are based on the affected area of the lesion; others are based on the size of the tumor. Although surgery remains the main treatment for this disease, the specific surgical approach, adjuvant drug therapy, and prognosis still need further exploration.


Asunto(s)
Neoplasias Cardíacas , Leiomiomatosis , Neoplasias Uterinas , Enfermedades Vasculares , Neoplasias Vasculares , Femenino , Humanos , Leiomiomatosis/diagnóstico , Leiomiomatosis/cirugía , Leiomiomatosis/patología , Neoplasias Uterinas/diagnóstico , Neoplasias Uterinas/patología , Neoplasias Uterinas/cirugía , Vena Cava Inferior , Estrógenos , Neoplasias Cardíacas/patología , Neoplasias Cardíacas/secundario , Neoplasias Vasculares/diagnóstico , Neoplasias Vasculares/cirugía , Neoplasias Vasculares/patología
3.
Zhonghua Yi Xue Za Zhi ; 100(6): 456-459, 2020 Feb 18.
Artículo en Chino | MEDLINE | ID: mdl-32146770

RESUMEN

Objective: To compare the curative effect of mesenchymal stem cells derived from human Wharton's Jelly(WJ-MSC) or adipose(AD-MSC) culture supernatant on endothelial cells angiogenesis. Methods: WJ-MSC and AD-MSC were isolated, identified, and the culture supernatant of stem cells was collected.The WJ-MSC or AD-MSC supernatant co-cultured with the endothelial cells. The expression levels of pro-angiogenic and anti-angiogenic genes of endothelial cells were assessed using qRT-PCR analysis, and the effects of stem cell culture supernatant on angiogenesis were evaluated by performing a tube formation assay in vitro. Results: After adding WJ-MSC and AD-MSC culture supernatant, the expression levels of pro-angiogenic genes in endothelial cells were upregulated, and the expression levels of anti-angiogenic genes were downregulated significantly in both experimental groups compared to the control group (P<0.01), and tube formation of endothelial cells was also significantly increased in both experimental groups as determined by the increase of the tube length ((43.2±9.2) mm vs (94.3±13.2)mm, (86.1±7.2)mm, P<0.01). Conclusion: The results showed that AD-MSC culture supernatant can promote endothelial cells angiogenesis and its curative effect is similar to that of WJ-MSC.


Asunto(s)
Células Madre Mesenquimatosas , Gelatina de Wharton , Adipocitos , Técnicas de Cultivo de Célula , Diferenciación Celular , Proliferación Celular , Técnicas de Cocultivo , Células Endoteliales , Humanos
4.
Genet Mol Res ; 14(4): 18731-42, 2015 Dec 29.
Artículo en Inglés | MEDLINE | ID: mdl-26782523

RESUMEN

Camellia ptilophylla, or cocoa tea, is naturally decaffeinated and its predominant catechins and purine alkaloids are trans-catechins and theobromine Regular tea [Camellia sinensis (L.) O. Ktze.] is evolutionarily close to cocoa tea and produces cis-catechins and caffeine. Here, the transcriptome of C. ptilophylla was sequenced using the 101-bp paired-end technique. The quality of the raw data was assessed to yield 70,227,953 cleaned reads totaling 7.09 Gbp, which were assembled de novo into 56,695 unique transcripts and then clustered into 44,749 unigenes. In catechin biosynthesis, leucoanthocyanidin reductase (LAR) catalyzes the transition of leucoanthocyanidin to trans-catechins, while anthocyanidin synthase (ANS) and anthocyanidin reductase (ANR) catalyze cis-catechin production. Our data demonstrate that two LAR genes (CpLAR1 and CpLAR2) by C. ptilophylla may be advantageous due to the combined effects of this quantitative trait, permitting increased leucoanthocyanidin consumption for the synthesis of trans-catechins. In contrast, the only ANS gene observed in C. sinensis (CsANS) shared high identity (99.2%) to one homolog from C. ptilophylla (CpANS1), but lower identity (~80%) to another (CpANS2). We hypothesized that the diverged CpANS2 might have lost its ability to synthesize cis-catechins. C. ptilophylla and C. sinensis each contain two copies of ANR, which share high identity and may share the same function. Transcriptomic sequencing captured two N-methyl nucleosidase genes named NMT1 and NMT2. NMT2 was highly identical to three orthologous genes TCS2, PCS2, and ICS2, which did not undergo methylation in vitro; in contrast, NMT1 was less identical to TCS, PCS and ICS, indicating that NMT1 may undergo neofunctionalization.


Asunto(s)
Camellia/genética , Regulación de la Expresión Génica de las Plantas , N-Glicosil Hidrolasas/genética , Oxidorreductasas/genética , Oxigenasas/genética , Proteínas de Plantas/genética , Transcriptoma , Antocianinas/biosíntesis , Cafeína/biosíntesis , Camellia/clasificación , Camellia/metabolismo , Camellia sinensis/clasificación , Camellia sinensis/genética , Camellia sinensis/metabolismo , Catequina/biosíntesis , Flavonoides/biosíntesis , Secuenciación de Nucleótidos de Alto Rendimiento , Isoenzimas/genética , Isoenzimas/metabolismo , N-Glicosil Hidrolasas/metabolismo , Oxidorreductasas/metabolismo , Oxigenasas/metabolismo , Filogenia , Proteínas de Plantas/metabolismo , Carácter Cuantitativo Heredable , Teobromina/biosíntesis
5.
Genet Mol Res ; 14(4): 19342-8, 2015 Dec 29.
Artículo en Inglés | MEDLINE | ID: mdl-26782587

RESUMEN

The aim of this study was to investigate the correlation between the expression of matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) and clinicopathological features of lung adenocarcinoma. The expression of MMP-9 and VEGF was evaluated by immunohistochemistry of 30 samples from lung adenocarcinoma patients and 12 paratumoral (normal) tissue samples. In addition, the change in VEGF or MMP-9 expression after MMP-9 or VEGF blockade, respectively, was measured using western blot in lung adenocarcinoma A549 cells. High expression of MMP-9 was found in 63.3% of adenocarcinoma tissues versus 16.7% in normal tissues (P < 0.05). High expression of VEGF was found in 70% of adenocarcinoma tissues versus 25% in normal tissues (P < 0.05). A positive correlation was identified between MMP-9 and VEGF expression (correlation coefficient = 0.7094, P < 0.001), and their mutual overexpression was associated with clinical staging and lymph node status (P < 0.05). In addition, an decrease in VEGF protein expression was observed after MMP-9 blockade by an MMP-9-specific monoclonal antibody. Similarly, a decrease in MMP-9 protein expression was found after VEGF blockade by a VEGF-specific monoclonal antibody. In conclusion, VEGF and MMP-9 are overexpressed in lung adenocarcinoma tissues, and they have a synergistic effect on the invasion and metastasis of adenocarcinoma.


Asunto(s)
Adenocarcinoma/genética , Adenocarcinoma/patología , Regulación Neoplásica de la Expresión Génica , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Metaloproteinasa 9 de la Matriz/genética , Factor A de Crecimiento Endotelial Vascular/genética , Adenocarcinoma/diagnóstico , Adenocarcinoma/metabolismo , Adenocarcinoma del Pulmón , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales/farmacología , Línea Celular Tumoral , Retroalimentación Fisiológica , Femenino , Humanos , Inmunohistoquímica , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/metabolismo , Metástasis Linfática , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Factor A de Crecimiento Endotelial Vascular/metabolismo
8.
Zhonghua Wai Ke Za Zhi ; 32(8): 492-3, 1994 Aug.
Artículo en Chino | MEDLINE | ID: mdl-7882777

RESUMEN

From June 1989 to April 1992, 5 patients with post-traumatic perinephric urinoma were treated by using percutaneous catheter drainage. The urinoma disappeared and the renal function restored in all the 5 patients 18-27 days (average 21.8 days) after continual drainage. Follow-up for 1-4 (averaging 2-6 years) years showed non-recurrence of the urinoma in all the 5 patients. The procedure is characterized by less distress and economical to the patients. It can keep the kidneys intact. The pathogenesis, pathology, diagnosis and treatment are discussed along with a review of the literature.


Asunto(s)
Enfermedades Renales Quísticas/cirugía , Riñón/lesiones , Orina , Adolescente , Adulto , Cateterismo , Niño , Drenaje/métodos , Femenino , Estudios de Seguimiento , Humanos , Enfermedades Renales Quísticas/etiología , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA